Literature DB >> 15757032

The investigation of primary rectal cancer by surgeons: current pattern of practice.

Todd P W McMullen1, Alexandra M Easson, Zane Cohen, Carol J Swallow.   

Abstract

OBJECTIVE: Selection of the optimal treatment strategy for patients with rectal cancer requires appropriate investigation, but published guidelines provide no clear consensus. We examined the current practice pattern for the investigation of primary rectal cancer by general surgeons in the province of Ontario, Canada.
METHODS: A telephone interview was completed by 124 surgeons in Ontario who manage patients with rectal cancer, who indicated the investigations they routinely perform in assessment before treatment. An exploratory cluster analysis was used to identify surgeon-related variables that predicted the pattern of investigation; these were tested in univariate and multivariate analyses.
RESULTS: Cluster analysis identified 3 distinct groups of surgeons based on patterns of test usage. Univariate analysis showed that the use of chest radiography, computed tomography of the abdomen and pelvis, and ultrasound of the abdomen varied significantly with the surgeon's subspecialty training, practice location and years in practice. Regression analysis confirmed that each of these 3 variables independently predicted the pattern of preoperative investigation. There were no significant predictors of the use of colonoscopy, sigmoidoscopy or carcinoembryonic antigen level. Over half of surgeons reported that they would have ordered additional imaging tests but did not because of lack of availability. The perceived desirability of additional tests, endorectal ultrasound in particular, varied with training.
CONCLUSIONS: The current practice pattern for the preoperative investigation of primary rectal cancer by general surgeons varies significantly with specific surgeon-related variables, with potential impact on the management and outcome of patients with rectal cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15757032      PMCID: PMC3211575     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  40 in total

1.  Recurrence and survival after total mesorectal excision for rectal cancer.

Authors:  R J Heald; R D Ryall
Journal:  Lancet       Date:  1986-06-28       Impact factor: 79.321

2.  Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.

Authors:  J J Tjandra; D M Reading; S A McLachlan; I F Gunn; M D Green; S J McLaughlin; J L Millar; J S Pedersen
Journal:  Dis Colon Rectum       Date:  2001-08       Impact factor: 4.585

3.  Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications.

Authors:  D Medich; J McGinty; D Parda; S Karlovits; C Davis; P Caushaj; B Lembersky
Journal:  Dis Colon Rectum       Date:  2001-08       Impact factor: 4.585

Review 4.  Surgeon influenced variables in resectional rectal cancer surgery.

Authors:  S D Wexner; N A Rotholtz
Journal:  Dis Colon Rectum       Date:  2000-11       Impact factor: 4.585

5.  Local excision of rectal cancer: what is the evidence?

Authors:  S Sengupta; J J Tjandra
Journal:  Dis Colon Rectum       Date:  2001-09       Impact factor: 4.585

6.  Routine use of transrectal ultrasound in rectal carcinoma: results of a prospective multicenter study.

Authors:  F Marusch; A Koch; U Schmidt; R Zippel; R Kuhn; S Wolff; M Pross; A Wierth; I Gastinger; H Lippert
Journal:  Endoscopy       Date:  2002-05       Impact factor: 10.093

7.  No downstaging after short-term preoperative radiotherapy in rectal cancer patients.

Authors:  C A Marijnen; I D Nagtegaal; E Klein Kranenbarg; J Hermans; C J van de Velde; J W Leer; J H van Krieken
Journal:  J Clin Oncol       Date:  2001-04-01       Impact factor: 44.544

8.  A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer.

Authors:  Gavin C Harewood; Maurits J Wiersema; Heidi Nelson; Robert L Maccarty; Janet E Olson; Jonathan E Clain; David A Ahlquist; Mary L Jondal
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

9.  Surgeon specialty is associated with outcome in rectal cancer treatment.

Authors:  Thomas E Read; Robert J Myerson; James W Fleshman; Robert D Fry; Elisa H Birnbaum; Bruce J Walz; Ira J Kodner
Journal:  Dis Colon Rectum       Date:  2002-07       Impact factor: 4.585

10.  Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture.

Authors:  R K Phillips; R Hittinger; L Blesovsky; J S Fry; L P Fielding
Journal:  Br J Surg       Date:  1984-01       Impact factor: 6.939

View more
  10 in total

1.  Appropriate preoperative investigations in the management of rectal cancer.

Authors:  Hartley S Stern
Journal:  Can J Surg       Date:  2005-02       Impact factor: 2.089

2.  Management of primary rectal cancer by surgeons in Atlantic Canada: results of a regional survey.

Authors:  Teong Kuan Chuah; Tracy Lee; Debrah Wirtzfeld; William Pollett
Journal:  Can J Surg       Date:  2010-12       Impact factor: 2.089

3.  Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the Cancer Care Outcomes Research and Surveillance Consortium.

Authors:  Mary E Charlton; Chi Lin; Dingfeng Jiang; Karyn B Stitzenberg; Thorvardur R Halfdanarson; Jane F Pendergast; Elizabeth A Chrischilles; Robert B Wallace
Journal:  Am J Clin Oncol       Date:  2013-12       Impact factor: 2.339

4.  Self-reported practice patterns and knowledge of rectal cancer care among Canadian general surgeons.

Authors:  Devon P Richardson; Geoff A Porter; Paul M Johnson
Journal:  Can J Surg       Date:  2014-12       Impact factor: 2.089

5.  Endoscopic Localization of Colon Cancer Is Frequently Inaccurate.

Authors:  Jennifer Nayor; Stephen R Rotman; Walter W Chan; Joel E Goldberg; John R Saltzman
Journal:  Dig Dis Sci       Date:  2017-05-02       Impact factor: 3.199

6.  Hospital Characteristics Associated with Stage II/III Rectal Cancer Guideline Concordant Care: Analysis of Surveillance, Epidemiology and End Results-Medicare Data.

Authors:  Mary E Charlton; Jennifer E Hrabe; Kara B Wright; Jennifer A Schlichting; Bradley D McDowell; Thorvardur R Halfdanarson; Chi Lin; Karyn B Stitzenberg; John W Cromwell
Journal:  J Gastrointest Surg       Date:  2015-12-09       Impact factor: 3.452

7.  Association between surgeon characteristics and their preferences for guideline-concordant staging and treatment for rectal cancer.

Authors:  Mary E Charlton; Lorren R Mattingly-Wells; Jorge E Marcet; Brenna C McMahon Waldschmidt; John W Cromwell
Journal:  Am J Surg       Date:  2014-06-08       Impact factor: 2.565

8.  Management of rectal cancer in Canada: an evidence-based comparison of clinical practice guidelines

Authors:  Zuhaib M. Mir; David Yu; Shaila J. Merchant; Christopher M. Booth; Sunil V. Patel
Journal:  Can J Surg       Date:  2020-01-22       Impact factor: 2.089

9.  Determinants of Rectal Cancer Patients' Decisions on Where to Receive Surgery: a Qualitative Analysis.

Authors:  Mary E Charlton; Ariana F Shahnazi; Irena Gribovskaja-Rupp; Lisa Hunter; Michele A Mengeling; Elizabeth A Chrischilles; Charles F Lynch; Marcia M Ward
Journal:  J Gastrointest Surg       Date:  2018-09-10       Impact factor: 3.452

Review 10.  Definition of the rectum and level of the peritoneal reflection - still a matter of debate?

Authors:  Jakub Kenig; Piotr Richter
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2013-03-26       Impact factor: 1.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.